Articles

• How long does it take for partial epilepsy to become intractable?

  A. T. Berg, J. Langfitt, S. Shinnar, B. G. Vickrey, M. R. Sperling, T. Walczak, C. Bazil, S. V. Pacia, S. S. Spencer

  • Abstract
  • Full Text
  • Full Text (PDF)
• The pathological basis of temporal lobe epilepsy in childhood

  C. Bocti, Y. Robitaille, P. Diadori, A. Lortie, C. Mercier, A. Bouthillier, L. Carmant

  • Abstract
  • Full Text
  • Full Text (PDF)
• A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

  F.G. Gilliam, F. Veloso, M.A.M. Bomhof, S.K. Gazda, V. Biton, J.P. Ter Bruggen, W. Neto, C. Bailey, G. Pledger, S.-C. Wu, the Topiramate EPMN 104 Study Group

  • Abstract
  • Full Text
  • Full Text (PDF)
• Spatial and motor neglect in children

  A. Laurent-Vannier, P. Pradat-Diehl, M. Chevignard, G. Abada, M. De Agostini

  • Abstract
  • Full Text
  • Full Text (PDF)
• Predictors and clinical impact of epilepsy after subarachnoid hemorrhage

  J. Claassen, S. Peery, K.T. Kreiter, L.J. Hirsch, E.Y. Du, E.S. Connolly, S.A. Mayer

  • Abstract
  • Full Text
  • Full Text (PDF)
• Febrile seizures and mesial temporal sclerosisNo association in a long-term follow-up study

  R. Tarkka, E. Pääkkö, J. Pyhtinen, M. Uhari, H. Rantala

  • Abstract
  • Full Text
  • Full Text (PDF)
• Multiple sclerosisNeurofilament light chain antibodies are correlated to cerebral atrophy

  M.J. Eikelenboom, A. Petzold, R.H.C. Lazeron, E. Silber, M. Sharief, E.J. Thompson, F. Barkhof, G. Giovannoni, C.H. Polman, B.M.J. Uitdehaag

  • Abstract
  • Full Text
  • Full Text (PDF)
• The pentapeptide QYNAD does not block voltage-gated sodium channels

  T.R. Cummins, M. Renganathan, P.K. Stys, R.I. Herzog, K. Scarfo, R. Horn, S.D. Dib-Hajj, S.G. Waxman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease

  F. Bernal, S. Shams’ili, I. Rojas, R. Sanchez-Valle, A. Saiz, J. Dalmau, J. Honnorat, P. Sillevis Smitt, F. Graus

  • Abstract
  • Full Text
  • Full Text (PDF)
• Early onset familial Alzheimer’s diseaseMutation frequency in 31 families

  J.C. Janssen, J.A. Beck, T.A. Campbell, A. Dickinson, N.C. Fox, R.J. Harvey, H. Houlden, M.N. Rossor, J. Collinge

  • Abstract
  • Full Text
  • Full Text (PDF)
• APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy

  Yoshio Tsuboi, Keith A. Josephs, Natalie Cookson, Dennis W. Dickson

  • Abstract
  • Full Text
  • Full Text (PDF)
• Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease

  D.A. Bennett, R.S. Wilson, J.A. Schneider, D.A. Evans, N.T. Aggarwal, S.E. Arnold, E.J. Cochran, E. Berry-Kravis, J.L. Bienias

  • Abstract
  • Full Text
  • Full Text (PDF)
• MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD

  C. R. Jack, M. Slomkowski, S. Gracon, T. M. Hoover, J. P. Felmlee, K. Stewart, Y. Xu, M. Shiung, P. C. O’Brien, R. Cha, D. Knopman, R. C. Petersen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Telephone screening for amnestic mild cognitive impairment

  Christopher R. Lines, Kathleen A. McCarroll, Richard B. Lipton, Gilbert A. Block

  • Abstract
  • Full Text
  • Full Text (PDF)
• Double dissociation of social functioning in frontotemporal dementia

  Katherine P. Rankin, Joel H. Kramer, Paula Mychack, Bruce L. Miller

  • Abstract
  • Full Text
  • Full Text (PDF)
• Carotid dissection with permanent and transient occlusion or severe stenosisLong-term outcome

  C. Kremer, M. Mosso, D. Georgiadis, E. Stöckli, D. Benninger, M. Arnold, R.W. Baumgartner

  • Abstract
  • Full Text
  • Full Text (PDF)
• Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency

  P.J. Kelly, K.L. Furie, J.P. Kistler, M. Barron, E.H. Picard, R. Mandell, V.E. Shih

  • Abstract
  • Full Text
  • Full Text (PDF)
• A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA

  S. Claiborne Johnston, Steve Sidney, Allan L. Bernstein, Daryl R. Gress

  • Abstract
  • Full Text
  • Full Text (PDF)
• Racial differences in survival post cerebral infarction among the elderly

  J. Bian, E.Z. Oddone, G.P. Samsa, J. Lipscomb, D.B. Matchar

  • Abstract
  • Full Text
  • Full Text (PDF)
• Stroke Impact Scale-16A brief assessment of physical function

  P.W. Duncan, S.M. Lai, R.K. Bode, S. Perera, J. DeRosa, the GAIN Americas Investigators

  • Abstract
  • Full Text
  • Full Text (PDF)
• Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes

  A. Caselli, J. Rich, T. Hanane, L. Uccioli, A. Veves

  • Abstract
  • Full Text
  • Full Text (PDF)
• Sera from Guillain-Barré patients enhance leakage in blood–nerve barrier model

  Takashi Kanda, Masanaga Yamawaki, Hidehiro Mizusawa

  • Abstract
  • Full Text
  • Full Text (PDF)
• Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants

  J. Turchan, C.B. Pocernich, C. Gairola, A. Chauhan, G. Schifitto, D.A. Butterfield, S. Buch, O. Narayan, A. Sinai, J. Geiger, J.R. Berger, H. Elford, A. Nath

  • Abstract
  • Full Text
  • Full Text (PDF)
• Acute migraine treatment with droperidolA randomized, double-blind, placebo-controlled trial

  S.D. Silberstein, W.B. Young, J.E. Mendizabal, J.F. Rothrock, A.S. Alam

  • Abstract
  • Full Text
  • Full Text (PDF)